Related Experiment Videos
Paramyxovirus strategies for evading the interferon response
Bin Gotoh1, Takayuki Komatsu, Kenji Takeuchi
1Department of Microbiology, Fukui Medical University School of Medicine, Shimoaizuki 23-3, Matsuoka-cho, Yoshida-gun, Fukui 910-1193, Japan. bin@fmsrsa.fukui-med.ac.jp
Reviews in Medical Virology
|November 1, 2002
Summary
Paramyxoviruses evade the interferon response using viral proteins C and V. These proteins inhibit interferon signaling through distinct mechanisms, offering insights into antiviral drug development.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Paramyxovirinae subfamily viruses, including Respirovirus and Rubulavirus, possess mechanisms to counteract host interferon (IFN) responses.
- Interferon signaling is crucial for antiviral defense, and its inhibition allows viral replication.
Purpose of the Study:
- To elucidate the molecular mechanisms by which Respirovirus (Sendai virus) and Rubulavirus inhibit interferon signaling.
- To identify the specific viral proteins responsible for this immune evasion.
Main Methods:
- Investigating the role of viral C and V proteins in interfering with the JAK-STAT pathway.
- Analyzing the effects of viral proteins on tyrosine phosphorylation of signal transducers and activators of transcription (STATs).
- Examining the involvement of proteasome-mediated degradation in viral immune evasion.
Main Results:
- Respirovirus (Sendai virus) C protein suppresses STAT tyrosine phosphorylation early in infection without degrading signaling components.
- Rubulavirus V protein induces proteasome-mediated degradation of Stat1 or Stat2.
- Both C and V proteins are multifunctional accessory proteins expressed from the P gene.
Conclusions:
- Understanding paramyxovirus evasion of the IFN response provides critical information for modulating the JAK-STAT pathway.
- These findings can guide the design of novel antiviral drugs and recombinant live vaccines.
- Insights gained can improve paramyxovirus expression vectors for gene therapy applications.